
AstraZeneca PLC (AZN) is currently trading at a key resistance area, with price consolidating around GBX 12,564 / GBX 12,556. This zone offers an attractive buy opportunity for short-term traders targeting a potential rebound toward the GBX 13,122 / GBX 13,196 level — aligning with the gap-down observed on September 4, 2025.
The next significant resistance zone stands at GBX 13,354, which could act as a profit-taking level before a possible retest or continuation higher.
Should downward pressure persist, a correction toward GBX 11,900 would represent a healthy retracement and potential accumulation point. A deeper dip toward the GBX 11,258 / GBX 11,460 gap-up zone would further strengthen long-term buying prospects.
From a broader technical perspective, long-term price targets remain at GBX 14,642 and GBX 15,688, contingent on market sentiment, sector strength, and upcoming earnings performance.
Outlook: